Tresiba 100 Unit

Tresiba 100 Unit is a long-acting insulin solution used for managing blood sugar levels in diabetes. This subcutaneous injection, manufactured by Novo Nordisk Canada Inc., is designed for consistent glucose control.

Tresiba 100 Unit is primarily used for the management of type 1 and type 2 diabetes. It helps regulate blood sugar levels over an extended period, making it suitable for daily use. People often ask, 'What is Tresiba used for?' It is commonly prescribed to maintain stable insulin levels throughout the day and night.

Tresiba 100 Unit works by providing a steady release of insulin, which helps the body utilize glucose more effectively. Common effects may include improved blood sugar control and reduced symptoms of hyperglycemia. Some users may experience localized reactions at the injection site.

Tresiba 100 Unit should be handled with care, ensuring proper storage and administration. It is important to follow healthcare provider instructions for use. Always check the solution for particles or discoloration before use. Monitor blood sugar levels regularly and be aware of potential signs of hypoglycemia.

Tresiba 100 Unit may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol consumption can also affect blood sugar levels, so it is advisable to monitor its effects closely. Always consult a healthcare provider before starting or stopping any medication.